Furthermore, it was reported that sFRP4 is overexpressed in pancreatic islet cells of patients with T2DM, while its increased circulatory concentrations impair insulin secretion by β-cells and thereby reduce glucose tolerance [51]. This evidence concerns the gene SFRP4 and type 2 diabetes mellitus.